Cardioprotective mechanisms of sodium-glucose cotransporter 2 inhibitors

The findings of large-scale cardiovascular outcome trials have been demonstrated that sodium-glucose cotransporter 2 ­inhibitors (iSGLT-2) have shown beneficial cardiovascular effects. In this review proposed mechanisms underlying iSGLT-2-associated cardiovascular benefits have been discussed: haemo...

Full description

Saved in:
Bibliographic Details
Main Authors: A. M. Mkrtumyan, T. N. Markova, N. K. Mishchenko
Format: Article
Language:English
Published: Endocrinology Research Centre 2021-09-01
Series:Сахарный диабет
Subjects:
Online Access:https://www.dia-endojournals.ru/jour/article/view/12541
Tags: Add Tag
No Tags, Be the first to tag this record!